These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 33794724)
1. Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome. Manrique P; Zhu Y; van der Oost J; Herrema H; Nieuwdorp M; de Vos WM; Young M Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33794724 [TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation alters gut phage communities in a clinical trial for obesity. Zuppi M; Vatanen T; Wilson BC; Golovina E; Portlock T; Cutfield WS; Vickers MH; O'Sullivan JM Microbiome; 2024 Jul; 12(1):122. PubMed ID: 38970126 [TBL] [Abstract][Full Text] [Related]
3. The success of fecal microbial transplantation in Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714 [No Abstract] [Full Text] [Related]
4. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial. Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731 [TBL] [Abstract][Full Text] [Related]
5. Species- and strain-level assessment using Benítez-Páez A; Hartstra AV; Nieuwdorp M; Sanz Y Gut Microbes; 2022; 14(1):2078621. PubMed ID: 35604764 [TBL] [Abstract][Full Text] [Related]
6. Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome. Smits LP; Kootte RS; Levin E; Prodan A; Fuentes S; Zoetendal EG; Wang Z; Levison BS; Cleophas MCP; Kemper EM; Dallinga-Thie GM; Groen AK; Joosten LAB; Netea MG; Stroes ESG; de Vos WM; Hazen SL; Nieuwdorp M J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581220 [TBL] [Abstract][Full Text] [Related]
8. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time. de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381 [TBL] [Abstract][Full Text] [Related]
9. Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome. van der Vossen EWJ; Bastos D; Stols-Gonçalves D; de Goffau MC; Davids M; Pereira JPB; Li Yim AYF; Henneman P; Netea MG; de Vos WM; de Jonge W; Groen AK; Nieuwdorp M; Levin E Gut Microbes; 2021; 13(1):1993513. PubMed ID: 34747338 [TBL] [Abstract][Full Text] [Related]
10. Faecal microbiota transplantations and the role of bacteriophages. Liu Q; Xu Z; Dai M; Su Q; Leung Chan FK; Ng SC Clin Microbiol Infect; 2023 Jun; 29(6):689-694. PubMed ID: 36414201 [TBL] [Abstract][Full Text] [Related]
11. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China. He J; He X; Ma Y; Yang L; Fang H; Shang S; Xia H; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Zhai C; Wang W; Jiang X; Xuan J; Liu M; Lu S; Li X; Wang H; Ouyang C; Cao M; Lin A; Zhang B; Wu D; Chen Y; Xiao C Microb Cell Fact; 2021 Nov; 20(1):216. PubMed ID: 34838016 [TBL] [Abstract][Full Text] [Related]
12. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice. Lin DM; Koskella B; Ritz NL; Lin D; Carroll-Portillo A; Lin HC Front Cell Infect Microbiol; 2019; 9():348. PubMed ID: 31750259 [TBL] [Abstract][Full Text] [Related]
13. Long-term colonisation with donor bacteriophages following successful faecal microbial transplantation. Draper LA; Ryan FJ; Smith MK; Jalanka J; Mattila E; Arkkila PA; Ross RP; Satokari R; Hill C Microbiome; 2018 Dec; 6(1):220. PubMed ID: 30526683 [TBL] [Abstract][Full Text] [Related]
15. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy. Kang Y; Cai Y Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509 [TBL] [Abstract][Full Text] [Related]
16. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation. Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ mBio; 2016 Dec; 7(6):. PubMed ID: 27999162 [TBL] [Abstract][Full Text] [Related]
17. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836 [TBL] [Abstract][Full Text] [Related]
18. Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation. Marotz CA; Zarrinpar A Yale J Biol Med; 2016 Sep; 89(3):383-388. PubMed ID: 27698622 [TBL] [Abstract][Full Text] [Related]
19. Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming. Yan ZX; Gao XJ; Li T; Wei B; Wang PP; Yang Y; Yan R Appl Environ Microbiol; 2018 Jul; 84(14):. PubMed ID: 29728388 [TBL] [Abstract][Full Text] [Related]
20. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans. Staley C; Khoruts A; Sadowsky MJ Arch Med Res; 2017 Nov; 48(8):766-773. PubMed ID: 29183720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]